alfuzosin hydrochloride

Generic: alfuzosin hydrochloride

Labeler: unichem pharmaceuticals (usa), inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name alfuzosin hydrochloride
Generic Name alfuzosin hydrochloride
Labeler unichem pharmaceuticals (usa), inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

alfuzosin hydrochloride 10 mg/1

Manufacturer
Unichem Pharmaceuticals (USA), Inc.

Identifiers & Regulatory

Product NDC 29300-155
Product ID 29300-155_8190595a-be8e-4fd0-bcdf-30b6ba64ef5a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203192
Listing Expiration 2026-12-31
Marketing Start 2016-03-15

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 29300155
Hyphenated Format 29300-155

Supplemental Identifiers

RxCUI
861132
UNII
75046A1XTN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name alfuzosin hydrochloride (source: ndc)
Generic Name alfuzosin hydrochloride (source: ndc)
Application Number ANDA203192 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-01)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-13)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-19)
source: ndc

Packages (3)

29300-155-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-01) 29300-155-13 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-13) 29300-155-19 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-19)

Ingredients (1)

alfuzosin hydrochloride (10 mg/1)

Linked Drug Pages (1)

Alfuzosin hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8190595a-be8e-4fd0-bcdf-30b6ba64ef5a", "openfda": {"unii": ["75046A1XTN"], "rxcui": ["861132"], "spl_set_id": ["644295a9-75cb-4326-a71f-b0f4e0c4cf75"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-01)", "package_ndc": "29300-155-01", "marketing_start_date": "20160315"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-13)", "package_ndc": "29300-155-13", "marketing_start_date": "20160315"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-155-19)", "package_ndc": "29300-155-19", "marketing_start_date": "20160315"}], "brand_name": "Alfuzosin hydrochloride", "product_id": "29300-155_8190595a-be8e-4fd0-bcdf-30b6ba64ef5a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "29300-155", "generic_name": "Alfuzosin hydrochloride", "labeler_name": "Unichem Pharmaceuticals (USA), Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alfuzosin hydrochloride", "active_ingredients": [{"name": "ALFUZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA203192", "marketing_category": "ANDA", "marketing_start_date": "20160315", "listing_expiration_date": "20261231"}